【新藥】《InveniAI 》成立全資子公司《AlphaMeld》，瞄準AI藥物發現與LLM

 【新藥】《InveniAI 》成立全資子公司《AlphaMeld》，瞄準AI藥物發現與LLM

 文章出處  

Globe Newswire 

 

 原文標題  

InveniAI Announces Launch of AlphaMeld Corporation and Major Milestone Updates to Reflect Cutting-Edge Innovation in AI-Driven Drug Discovery 

 

 Twitter  

https://x.com/aimedadviser/status/1879327548871688418 

 

 文章序號  

7083 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2025 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.